South Korean Panel Recommends Moderna's Covid Vaccine Eligible For Use

Moderna Inc.'s Covid-19 vaccine has been recommended in South Korea by a panel of experts, news agency Yonhap reported. As per the panel, the vaccine showed more than a 94 percent efficacy rate and is eligible for use. The panel's review is the first step of three separate independent evaluations before the Ministry of Food and Drug Safety gives final approval for the vaccine.